arrow
P

Pauline Corbaux

Univ Lyon 1
H指数:10
被引数:414

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal Human Epididymis Protein 4 Kinetics in First-Line Treatment of Advanced Ovarian Carcinoma: Mathematical Modeling and Prognostic Implications

一线治疗晚期卵巢癌中的人附睾蛋白4动力学:数学建模与预后意义

2026-09-110
OAAI
Response to Correspondence on “Differences in first-line chemosensitivity assessed by KELIM in advanced serous ovarian cancer: evidence from Western and Japanese trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis”

对“Gynecologic Cancer InterGroup (GCIG)荟萃分析中西方和日本试验评估的晚期浆液性卵巢癌一线化疗敏感性差异”一文的读者来信的回复

2026-07-100
PRE
Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications

人附睾蛋白4在复发性晚期卵巢癌铂类化疗中的纵向动力学:数学建模及预后意义

2026-07-030
OAAI
Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trial

新诊断卵巢癌患者新辅助化疗期间循环核小体的基线值和纵向动力学:来自随机II期CHIVA试验GINECO/GINEGEPS研究的结果

2026-07-010
OAAI
Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis

KELIM评估的晚期浆液性卵巢癌一线化疗敏感性差异:源自妇科肿瘤协作组(GCIG)荟萃分析的西方与日本试验证据

2026-06-160
PREAI
Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter Study

复发性或转移性鼻窦癌的系统治疗:一项回顾性多中心研究

2026-01-010
OAAI
Identifying High-Risk Relapse in Early-Stage I–II Ovarian Cancer Using the CA-125 ELIMination rate constant K (KELIM) Score: A GCIG Individual Patient Data Meta-analysis

使用CA-125 ELIMination率常数K (KELIM)评分识别早期I-II期卵巢癌的高复发风险:一项GCIG个体患者数据荟萃分析

2025-10-100
OAAI
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study

复发卵巢癌患者中结合肿瘤大小动态和CA-125动力学的一种联合K-PD模型的预后价值:BOLD二期GINECO研究

2025-07-070
OA
Difference Of Chemosensitivity Between Western And Japanese Women In First-Line Setting Of Advanced Serous Ovarian Cancer: Data From The MAOV Individual Patient Data Meta-Analysis

西方与日本女性在晚期浆液性卵巢癌一线治疗中的化疗敏感性差异:来自MAOV个体患者数据Meta分析的数据

2025-02-010
PRE
Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials

通过模拟CA-125 KELIM评估肿瘤原发性化疗敏感性,以预测接受新辅助化疗和免疫治疗治疗的卵巢癌患者完全间隔减瘤术(IDS)的作用:一项GINEGEPS/GINECO研究,来自NeoPembrOv和INeOV试验

2024-09-010
PRE
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first- line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
2023-09-018
OAAI